Longevinex applied-for-patent (United States Patent Office file # 20050158376, filed Oct. 25, 2004) describes a nutraceutical matrix designed to enhance the absorption, bioavailability, and molecular stability of resveratrol in a manner similar to a proprietary resveratrol drug now undergoing human clinical investigation. When you order, you will receive the genuine patent-applied for nutraceutical matrix heralded and consumed by laboratory researchers themselves. 4th Generation Longevinex ADVANTAGE. First dietary supplement to address aging of cells and connective tissue. Same dosage of nutrients in Longevinex plus added lutein and extracts from green tea, grape seed and cocoa beans. 60 vege-caps per box, suggested dosage 1-2 caps per day. Limited time introductory offer.
Other products in the category Longevinex Product:
|
Longevinex® Scientifically Proven 9 Times More Effective Than Plain Resveratrol or Calorie Restrictioncompare products |
|||
LOOKING FOR AUTOSHIP?With Longevinex's proven long shelf life, buy quantity instead and save the multiple shipping costs. ATTENTION:
|
|||
|
These statements have not been evaluated by the Food & Drug administration. ©2009 Resveratrol Partners, LLC |
|||